相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tissue plasminogen activator-based nanothrombolysis for ischemic stroke
Shan Liu et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study
Bruce C. V. Campbell et al.
INTERNATIONAL JOURNAL OF STROKE (2018)
Thrombectomy of calcified emboli in stroke. Does histology of thrombi influence the effectiveness of thrombectomy?
Tomas Dobrocky et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2018)
Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO--MMP-9 Pathway
Hansen Chen et al.
TRANSLATIONAL STROKE RESEARCH (2018)
Fibrin Clot Architecture in Acute Ischemic Stroke Treated With Mechanical Thrombectomy With Stent-Retrievers - Cohort Study
Dagmar Krajickova et al.
CIRCULATION JOURNAL (2018)
Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury
Candela Diaz-Canestro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Autophagy- and MMP-2/9-mediated Reduction and Redistribution of ZO-1 Contribute to Hyperglycemia-increased Blood-Brain Barrier Permeability During Early Reperfusion in Stroke
Shuai Zhang et al.
NEUROSCIENCE (2018)
Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke
Satish Singh et al.
NEUROSCIENCE (2018)
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
R. G. Hart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3)
Gregory W. Albers et al.
INTERNATIONAL JOURNAL OF STROKE (2017)
A first-in-human study of DS-1040, an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor, in healthy subjects
J. Zhou et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Fibrinolysis: from blood to the brain
R. L. Medcalf
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial
Nicola Logallo et al.
LANCET NEUROLOGY (2017)
Tenecteplase in ischemic stroke offers improved recanalization Analysis of 2 trials
Andrew Bivard et al.
NEUROLOGY (2017)
Ischemic Stroke What Does the Histological Composition Tell Us About the Origin of the Thrombus?
Peter B. Sporns et al.
STROKE (2017)
Potential Biological Markers of Atrial Fibrillation: A Chance to Prevent Cryptogenic Stroke
Istvan Szegedi et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Astrocytes regulate the balance between plasminogen activation and plasmin clearance via cell-surface actin
Aurelien Briens et al.
CELL DISCOVERY (2017)
Tissue plasminogen activator mediates deleterious complement cascade activation in stroke
Xue-Jun Zhao et al.
PLOS ONE (2017)
Assessing the efficacy of endovascular therapy in stroke treatments: updates from the new generation of trials
Gregory B. Walker et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2017)
The plasminogen activation system in neuroinflammation
Anupriya Mehra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Histologic features of acute thrombi retrieved from stroke patients during mechanical reperfusion therapy
Seong Hwan Ahn et al.
INTERNATIONAL JOURNAL OF STROKE (2016)
Thrombus Histology Suggests Cardioembolic Cause in Cryptogenic Stroke
Tobias Boeckh-Behrens et al.
STROKE (2016)
Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor-1 Reduces Ischemic Brain Damage in Mice
Frederik Denorme et al.
STROKE (2016)
Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure
Sara J. Henderson et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Activated protein C promotes neuroprotection: mechanisms and translation to the clinic
John H. Griffin et al.
THROMBOSIS RESEARCH (2016)
Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic Stroke
Renee J. Turner et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis
Travis J. Gould et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
The changes in clot microstructure in patients with ischaemic stroke and the effects of therapeutic intervention: a prospective observational study
Sophia N. Stanford et al.
BMC NEUROLOGY (2015)
Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials
Partha Sardar et al.
EUROPEAN HEART JOURNAL (2015)
Evaluation of and recommendation for the nomenclature of the CPB2 gene product (also known as TAFI and proCPU): communication from the SSC of the ISTH
J. H. Foley et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Plasmin-Loaded Echogenic Liposomes for Ultrasound-Mediated Thrombolysis
Madhuvanthi A. Kandadai et al.
TRANSLATIONAL STROKE RESEARCH (2015)
Atrial Fibrillation in Patients with Cryptogenic Stroke
David J. Gladstone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clot properties and cardiovascular disease
Katherine I. Bridge et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Clot composition and treatment approach to acute ischemic stroke: The road so far
Paramdeep Singh et al.
ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2013)
Insights into thrombin activatable fibrinolysis inhibitor function and regulation
J. H. Foley et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1
Shih-Hon Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
An Updated Definition of Stroke for the 21st Century A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Ralph L. Sacco et al.
STROKE (2013)
A High Affinity Interaction of Plasminogen with Fibrin Is Not Essential for Efficient Activation by Tissue-type Plasminogen Activator
Paul Y. Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model
Susan T. Laing et al.
THROMBOSIS RESEARCH (2012)
Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells
Yuko Suzuki et al.
BLOOD (2011)
The plasmin-antiplasmin system: structural and functional aspects
Johann Schaller et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
CT and MRI Early Vessel Signs Reflect Clot Composition in Acute Stroke
David S. Liebeskind et al.
STROKE (2011)
Neuroserpin Protects Neurons from Ischemia-Induced Plasmin-Mediated Cell Death Independently of Tissue-Type Plasminogen Activator Inhibition
Jialing Wu et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Blood-brain barrier permeability and tPA-mediated neurotoxicity
Rami Abu Fanne et al.
NEUROPHARMACOLOGY (2010)
Fibrin clot properties in acute ischemic stroke: relation to neurological deficit
Anetta Undas et al.
THROMBOSIS RESEARCH (2010)
Transcranial Ultrasound in Clinical Sonothrombolysis (TUCSON) Trial
Carlos A. Molina et al.
ANNALS OF NEUROLOGY (2009)
Altered Fibrin Clot Structure/Function in Patients With Cryptogenic Ischemic Stroke
Anetta Undas et al.
STROKE (2009)
Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment
Guido Stoll et al.
BLOOD (2008)
Cryptogenic stroke: time to determine aetiology
F. Guercini et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
DO BUBBLE CHARACTERISTICS AFFECT RECANALIZATION IN STROKE PATIENTS TREATED WITH MICROBUBBLE-ENHANCED SONOTHROMBOLYSIS?
Marta Rubiera et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2008)
Structure of fibrin: impact on clot stability
J. W. Weisel
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Adhesion mechanisms in platelet function
Zaverio M. Ruggeri et al.
CIRCULATION RESEARCH (2007)
The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease
P. Y. Kim et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
Hashem M. Shaltoni et al.
STROKE (2007)
Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin
M Schneider et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective
T Cheng et al.
NATURE MEDICINE (2003)
Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein
M Yepes et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin
TJ Podor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed - Dynamic and structural approaches by confocal microscopy
JP Collet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
